SEC
ATRC icon

Seven Eight Capital’s AtriCure ATRC Stock Holding History

Seven Eight Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,646
Closed -$202K – 693
2024
Q1 		$202K Sell
6,646
-6,116
-48% -$205K 0.02% 571
2023
Q4 		$455K Buy
+12,762
New +$475K 0.05% 436

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Seven Eight Capital's ATRC Position: Q2 2024 in Review

Seven Eight Capital sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 6,646 shares — an estimated $202K sold.

Seven Eight Capital first reported a position in ATRC in Q4 2023 and held it in 2 quarters. The position peaked at $455K in Q4 2023. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Seven Eight Capital reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Seven Eight Capital sold 6,646 AtriCure shares in Q2 2024, an estimated $202K.
  • Seven Eight Capital first reported a position in AtriCure in Q4 2023 and held it in 2 quarters.
  • Seven Eight Capital's AtriCure position peaked at $455K in Q4 2023.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.